Vipul Parikh, MD
Geriatric Medicine · Toms River, NJNPI 1518982958
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AstraZeneca at 41.8% of the total. Reporting peaked in 2024 at $1,385 and has fallen 52.3% since, to $660 in 2025.
Across 132 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$447
- Boston Scientific$210
- Silk Road Medical, Inc.$122
- BD$121
- Sumitomo Pharma America, Inc.$102
- plus $859 from 25 others
What the payments were for
- Food & beverage$3,197100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $1,336 |
| GSK | 30 | $447 |
| Boston Scientific | 2 | $210 |
| Silk Road Medical, Inc. | 1 | $122 |
| BD | 1 | $121 |
| Sumitomo Pharma America, Inc. | 6 | $102 |
| Bayer | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Johnson & Johnson | 5 | $68 |
| Novo Nordisk | 4 | $58 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Baxter Healthcare | 1 | $53 |
| AbbVie | 3 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Novartis | 2 | $41 |
| Viatris Specialty LLC | 2 | $39 |
| Philips North America LLC | 2 | $37 |
| Pfizer | 2 | $36 |
| Sunovion Pharmaceuticals Inc. | 2 | $27 |
| Strongbridge US Inc. | 2 | $26 |
| Abbott | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,197 in reported general payments places this provider in the 85th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 583 | $329,565 |
| XareltoRivaroxaban | 99 | $88,053 |
| FarxigaDapagliflozin Propanediol | 75 | $79,377 |
| EntrestoSacubitril/Valsartan | 90 | $55,318 |
| JanuviaSitagliptin Phosphate | 74 | $55,117 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $54,868 |
| JardianceEmpagliflozin | 76 | $52,859 |
| Breo ElliptaFluticasone/Vilanterol | 71 | $42,642 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $32,426 |
| LinzessLinaclotide | 37 | $21,909 |
| MyrbetriqMirabegron | 22 | $21,101 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 39 | $20,999 |
| CopaxoneGlatiramer Acetate | 12 | $18,508 |
| BrilintaTicagrelor | 22 | $17,985 |
| OzempicSemaglutide | 12 | $17,523 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Retacrit, Abrysvo | $36 | $355,967639 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $1,336 | $129,788121 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $447 | $111,059153 claims |
| Johnson & JohnsonXarelto, Procrit | $68 | $101,666113 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $20 | $73,858115 claims |
| NovartisEntresto | $41 | $55,31890 claims |
| AbbVieLinzess | $48 | $21,90937 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $18 | $18,50812 claims |
| Novo NordiskOzempic | $58 | $17,52312 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $68 | $11,33211 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $102 | $6,05620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Toms River
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
- Leslie FeiginDenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.